Rogers JE, Wang X, Trail A, Ajani JA, et al. Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing? Oncology 2022;100:182-187.
PMID: 34969028